[HTML][HTML] Low plasma levels of irisin predict acutely decompensated heart failure in type 2 diabetes mellitus patients with chronic heart failure

AA Berezin, AB Obradovic, IM Fushtey… - Journal of …, 2023 - mdpi.com
The aim of this study was to determine the discriminative value of irisin for acutely
decompensated heart failure (ADHF) in type 2 diabetes mellitus (T2DM) patients with …

[HTML][HTML] Circulating Myokines as Novel Biomarkers for Cardiovascular Diseases

J Lyu, D Guo, Y Song, M Zhang, F Ge… - Reviews in …, 2024 - imrpress.com
Myokines are a group of cytokines or polypeptides released from skeletal muscle during
exercise. Growing evidence suggests that myokines are associated with the development of …

[HTML][HTML] Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart Failure

TA Berezina, OO Berezin, UC Hoppe, M Lichtenauer… - Biomedicines, 2024 - mdpi.com
The purpose of the study is to elucidate whether irisin is a promising predictive biomarker for
kidney-related events in patients with T2DM and concomitant asymptomatic HF. We …

Diagnostic and predictive abilities of myokines in patients with heart failure

OO Berezin, TA Berezina, UC Hoppe… - Advances in …, 2024 - pubmed.ncbi.nlm.nih.gov
Myokines are defined as a heterogenic group of numerous cytokines, peptides and
metabolic derivates, which are expressed, synthesized, produced, and released by skeletal …

Diagnostic and therapeutic aspects of irisin in cardiovascular pathology and metabolic disorders

AM Alieva, IG Nikitin, NV Teplova, IE Baykova… - Therapy, 2023 - journals.eco-vector.com
Despite significant advances in medicine, cardiovascular disease continues to be the
leading cause of death worldwide. An important task of modern cardiology is the search and …